Antibody-Dependent Enhancement of SARS-CoV-2 Infection of Human Immune Cells: In Vitro Assessment Provides Insight in COVID-19 Pathogenesis

Patients with COVID-19 generally raise antibodies against SARS-CoV-2 following infection, and the antibody level is positively correlated to the severity of disease. Whether the viral antibodies exacerbate COVID-19 through antibody-dependent enhancement (ADE) is still not fully understood. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xu-Rui, Li, Qian, Li, Hui-Ling, Wang, Xi, Wang, Qi, Zheng, Xiao-Shuang, Geng, Rong, Zhang, Yu-Lan, Li, Bei, Jiang, Ren-Di, Liu, Mei-Qin, Zhu, Yan, Zhang, Wei, Yang, Xing-Lou, Peng, Ke, Zhou, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704563/
https://www.ncbi.nlm.nih.gov/pubmed/34960752
http://dx.doi.org/10.3390/v13122483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704563/
https://www.ncbi.nlm.nih.gov/pubmed/34960752
http://dx.doi.org/10.3390/v13122483

Ejemplares similares